Should You Buy Zoetis Before Feb. 12?

Zoetis is set to report Q4 and full-year 2025 results pre-market on Feb. 12 with sell‑side forecasts calling for $2.36 billion in revenue (up ~1.9% year‑over‑year) and roughly $1.40 in EPS (flat). The company has a recent history of beating EPS but lowered full‑year 2025 revenue guidance last quarter due to macro headwinds in its livestock business; continued weakness or disappointing FY2026 guidance could pressure the stock further (shares are ~11% below the Q3 report). Valuation has compressed from near 30x forward EPS a year ago to under 20x today (vs. competitor Elanco at ~23x), so guidance alignment with expectations will likely determine investor reaction and near‑term price action.

Analysis

Market structure: Zoetis (ZTS) is the clear short-term loser if Feb. 12 guidance repeats last quarter’s walkback; companion-animal drug uptake (Librela/Solensia) and livestock demand are the direct levers. Competitors (e.g., ELAN) could gain share if Zoetis’ execution stalls, but overall pricing power across animal health looks pressured — implied by valuation compression from ~30x to <20x forward EPS. Cross-asset: a material miss would lift equity vols (ZTS + peers), modestly tighten IG spreads as risk-off hits staples, and push FX into safe-haven USD strength; commodity protein prices will amplify livestock demand signals.

Risk assessment: Tail risks include a regulatory safety action on Librela/Solensia, a sudden livestock demand shock tied to protein price moves, or a large FY26 guidance cut that forces >15% EPS downgrades. Time horizons split cleanly: immediate (0–7 days) — earnings-driven vol and directional move; short-term (1–3 months) — guidance digestion and analyst revisions; long-term (6–24 months) — product lifecycle and M&A/competitive shifts. Hidden dependencies: vet adoption curves, distributor inventory digestion, and emerging-market FX exposures can magnify minor guidance tweaks.

Trade implications: For event traders, prefer limited-risk option structures into Feb.12: buy a 2-week ATM straddle (expiry ~Feb 21) sized to 0.5% portfolio risk or buy an ATM put / 10–15% OTM put spread to cap cost. Longer-term: if post-earnings guidance is stable or upgraded, initiate a 2–3% long ZTS position (target 12–18% in 6–12 months; stop-loss 12%). Relative trade: long ZTS / short ELAN (1:1 dollar) if guidance surprises positive, aiming to capture valuation convergence from <20x toward peer ~23x.

Contrarian angles: The market may be over-discounting recurrence of November-style panic; a modest beat + steady guidance could produce a >15% snap-back as forward multiple normalizes. Conversely, a beat with conservative FY26 commentary can still trigger selling — so price action, not just EPS beat, matters. Historical parallels: prior quarters where guidance was walked back then conservative re-affirmation produced 10–20% moves; use that as a baseline for sizing and stops.

Key Decisions for Investors

• Event trade (short-term): Buy a ZTS 2-week ATM straddle expiring ~Feb 21 sized to 0.5% of portfolio risk to capture the post-earnings move; if premium is high, substitute with an ATM put / 10–15% OTM put spread to limit cost.
• Protect existing longs: Purchase Feb weekly puts or a put spread (buy ATM, sell 10–15% OTM) sized to protect 1–2% of portfolio exposure through Feb 21; unwind if implied vol falls >25% post-earnings.
• Post-earnings accumulation (swing): If guidance is stable or improved, establish a 2–3% long position in ZTS within 1–3 trading days after the print, target +12–18% in 6–12 months, set a hard stop at -12%.
• Relative value pair: If ZTS guidance beats and valuation re-rates, enter long ZTS / short ELAN (ELAN ticker) 1:1 dollar exposure sized 1–2% total capital to capture multiple convergence toward ~23x over 6–12 months.
• Trigger-based monitoring: Track three metrics in next 30–90 days — FY26 revenue guidance change (> -3% vs consensus), monthly Librela/Solensia script growth (< +5% m/m), and livestock revenue trend; if any trigger fires, cut ZTS exposure by 50% within 72 hours.